To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of section 122(3) of the Companies Act

Release Date: 15/08/2019 13:33
Code(s): APN     PDF:  
 
Wrap Text
Notification in terms of section 122(3) of the Companies Act

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Group”)

NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(b) OF THE
JSE LISTINGS REQUIREMENTS

In accordance with section 122(3)(b) of the Companies Act, No. 71 of 2008 (“the Act”) and paragraph
3.83(b) of the JSE Listings Requirements, holders of ordinary shares in the Company are advised that Allan
Gray (Pty) Limited has formally notified the Company that it has increased its beneficial interest in the
securities of the Company, which it holds on behalf of its clients, to 5.0066% of the ordinary share capital of
the Company, effective 13 August 2019.

Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section
122(3)(a) of the Act.



Durban
15 August 2019



Sponsor:
Investec Bank Limited

Date: 15/08/2019 01:33:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story